Category of harm HMPS method | HMPS method after review stage 2 | HMPS method after review stage 3 | ||
---|---|---|---|---|
n(%) of AEs | n(%) of preventable AEs | n(%) of AEs | n(%) of preventable AEs | |
Minimal impairment, recovery within 1 month | 116 (76.8) | 104 (89.7) | 120 (77.4) | 108 (90.0) |
Moderate impairment, recovery within 1 to 6 months | 20 (13.2) | 17 (85.0) | 20 (12.9) | 17 (85.0) |
Moderate impairment, recovery within 6 to 12 months | 9 (6.0) | 6 (66.7) | 9 (5.8) | 6 (66.7) |
Permanent impairment, degree of disability <50% | 4 (2.6) | 3 (75.0) | 4 (2.6) | 3 (75.0) |
Permanent impairment, degree of disability >50% | 1 (0.7) | 1 (100.0) | 1 (0.6) | 1 (100.0) |
Contributed to patient death | 1 (0.7) | 0 (0.0) | 1 (0.6) | 0 (0.0) |
Unable to determine | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Total n of AE | 151 (100.0) | 131 (86.8) | 155 (100.0) | 135 (87.1) |
Category of harm GTT | GTT after review stage 2 | GTT after review stage 3 | ||
n (%) of AEs | n (%) of preventable AEs | n (%) of AEs | n (%) of preventable AEs | |
E Contributed to or resulted in temporary harm to the patient and required intervention | 51 (51.5) | 41 (80.4) | 78 (56.9) | 63 (80.8) |
F Contributed to or resulted in temporary harm to the patient and required initial or prolonged hospitalisation | 42 (42.4) | 31 (73.8) | 51 (37.2) | 40 (78.4) |
G Contributed to or caused permanent patient harm | 5 (5.1) | 5 (100.0) | 7 (5.1) | 7 (100.0) |
H Intervention required to sustain life | 1 (1.0) | 0 (0.0) | 1 (0.7) | 0 (0.0) |
I Contributed to patient death | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Total n of AE | 99 (100.0) | 77 (77.8) | 137 (100.0) | 110 (80.3) |